The Role of Oral Metronidazole in the Management of Post Haemorrhoidectomy Pai

Phase 3

• Conditions: Haemorrhoidal disease; Surgery - Other surgery; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12619000492156
• Lead Sponsor: Dr Grahame Ctercteko

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-26
• Last Update Posted: 15 July 2019

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

oAge greater than or equal to 18 years old
oPatient with grade III/IV internal haemorrhoids and/or external haemorrhoids, presenting for elective excisional open haemorrhoidectomy
oPatient capable of participating in informed consent for the study
oPatient willing to complete follow-up over the study period (6 weeks)

Exclusion Criteria

oPatient unable or not willing to consent to procedure
oPatient allergy to metronidazole
oPatients who are immune suppressed
oIf patient receives any antibiotics during the 6-week trial period
oChronic kidney disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Post-operative pain days 1-7. This be assessed by using a Visual Analogue Score (VAS) ranging from 0-10 at each of these time points. [Days 1-7 post operation (this will be assessed daily during this time period). ]